Vox Markets Logo

FTSE 100 movers: 3i Group rallies on results; Hikma goes ex-div

15:49, 21st March 2024

London's FTSE 100 was 2% higher at 7,889.97 in afternoon trade on Thursday.

3i Group was among the top performers as it said in its third-quarter results that its largest portfolio company, the Benelux discount retailer Action, recorded notable growth in the 2023 financial year.

Net sales reached €11.32bn and operating EBITDA hit €1.62bn, marking a 28% and 34% increase, respectively, compared to 2022.

Shares in fashion retailer Next jumped as it held guidance for 2024 after posting a better-than-expected 5% rise in annual profits and flagged lower prices for customers this year.

The company said it still expected pre-tax earnings of £960m, based on a 2.5% increase in full price sales.

Total sales for the year to January 2024 rose 6% to £5.8bn, while pre-tax profit of £918m beat an already upgraded forecast of £915m.

On the downside, Hikma, British American Tobacco and Schroders all lost ground as they traded without entitlement to the dividend.

FTSE 100 - Risers

St James's Place (STJ) 457.00p 9.25%
3i Group (III) 2,748.00p 8.83%
Anglo American (AAL) 1,953.60p 7.26%
Airtel Africa (AAF) 96.65p 6.56%
Halma (HLMA) 2,346.00p 6.25%
JD Sports Fashion (JD.) 117.30p 6.11%
Melrose Industries (MRO) 658.20p 6.02%
Ocado Group (OCDO) 488.30p 5.90%
Next (NXT) 8,972.00p 5.83%
Croda International (CRDA) 4,996.00p 5.76%

FTSE 100 - Fallers

Hikma Pharmaceuticals (HIK) 1,865.00p -2.51%
Burberry Group (BRBY) 1,201.00p -2.36%
Smith & Nephew (SN.) 1,033.50p -2.32%
Prudential (PRU) 762.60p -2.31%
British American Tobacco (BATS) 2,364.50p -1.97%
Reckitt Benckiser Group (RKT) 4,291.00p -1.76%
Centrica (CNA) 126.00p -1.75%
Schroders (SDR) 377.00p -0.92%
Unilever (ULVR) 3,895.50p -0.85%
B&M European Value Retail S.A. (DI) (BME) 529.00p -0.56%

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
Watchlist